Publications by authors named "J KLARNET"

Claim this Profile
H
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
L A Holmberg, T Demirer, S Rowley, C D Buckner, G Goodman, J Klarnet

Bone Marrow Transplant· October 1998

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
K Schiffman, C D Buckner, R Maziarz, D G Maloney, F R Appelbaum, J Klarnet

Biol Blood Marrow Transplant· November 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.
W I Bensinger, K S Schiffman, L Holmberg, F R Appelbaum, R Maziarz, J P Klarnet

Bone Marrow Transplant· June 1997

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.
K S Schiffman, W I Bensinger, F R Appelbaum, S Rowley, K Lilleby, J P Klarnet

Bone Marrow Transplant· June 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
W I Bensinger, S D Rowley, T Demirer, K Lilleby, K Schiffman, J Klarnet

J Clin Oncol· May 1996

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis